You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Dipropylacetate (DPA) treatment in epileptic patients caused significant hyperglycinemia, marked by increased glycine levels in plasma and cerebrospinal fluid, and a fourfold rise in urinary glycine excretion. This suggests DPA-induced hyperglycinemia may resemble secondary hyperglycinemia seen in organic acidurias.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: